Ishwarya Shradha Mamidi

Ishwarya Shradha Mamidi

Auto-generated profile, based on publicly available information

Ishwarya Shradha Mamidi

Division of Plastic and Reconstructive Surgery, Children’s National Hospital, Washington, DC, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
SFScott Fassas
Scott Fassas
IMIshwarya Mamidi
Ishwarya Mamidi
RLRyan Lee
Ryan Lee
LPLuke Pasick
Luke Pasick
DBDaniel A. Benito
Daniel A. Benito
JGJoseph Goodman
Joseph Goodman

1 July 2021 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
PDF file
IMIshwarya S. Mamidi
Ishwarya S. Mamidi
AGAlex Gu
Alex Gu
CMCollin F. Mulcahy
Collin F. Mulcahy
CWChapman Wei
Chapman Wei
PZPhilip E. Zapanta
Philip E. Zapanta
Objectives: Recently, the decision was made to transition the United States Medical Licensing Examination (USMLE) Step 1 score from a three-digit numerical score to a pass/fail system. Historically, Step 1 scores have been important for otolaryngology resident applicant selection. The purpose of this study was to understand and evaluate otolaryngology residency program directors’ (OPDs) opinions on the impact following the change in Step 1 score reporting. Methods: A 22-question survey administered through Qualtrics was sent to 113 academic otolaryngology residency program directors in April 2020. Information about demographics, impressions on the new Step 1 score format, anticipated changes in applicant selection, impact on mental health, and importance of various other factors in selecting applicants were queried. Descriptive statistics were used to analyze survey results. Results: A total of 41 out of 113 (36.3%) OPDs completed this survey. A majority of surveyed OPDs (80.5%) do not support the decision to change Step 1 to a pass/fail system. In the absence of a three digit numeric USMLE Step 1 score, OPDs indicated prioritization of away rotations, letters of recommendation (LORs), personal prior knowledge of the applicant, grades in required clerkship, and class ranking or quartile. 53.7% of OPDs anticipate requiring USMLE Step 2 Clinical Knowledge for interview consideration following this change. Conclusion: OPDs believe a pass/fail Step 1 score will decrease the importance of this exam and that this change will lead to the implementation and evaluation of additional metrics such as a required Step 2 CK score.

1 January 2021 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
IMIshwarya S. Mamidi
Ishwarya S. Mamidi
DBDaniel A. Benito
Daniel A. Benito
RLRyan Lee
Ryan Lee
PTPunam G. Thakkar
Punam G. Thakkar
JGJoseph Goodman
Joseph Goodman
AJArjun S. Joshi
Arjun S. Joshi

4 May 2021 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Closed access
PDF file
JSJason R. Stein
Jason R. Stein
EMEsperanza Mantilla-Rivas
Esperanza Mantilla-Rivas
MAMarudeen Aivaz
Marudeen Aivaz
SRSohel Rana
Sohel Rana
IMIshwarya Shradha Mamidi
Ishwarya Shradha Mamidi
AOAlbert K. Oh
Albert K. Oh
Objective: To analyze safety and efficacy of single-dose ketorolac after primary palatoplasty (PP). Design: Consecutive cohort of patients undergoing PP, comparing to historical controls. Setting: A large academic children’s hospital. Patients, Participants: A consecutive cohort of 111 patients undergoing PP (study n = 47) compared to historical controls (n = 64). Interventions: All patients received intraoperative acetaminophen, dexmedetomidine, and opioids while the study group received an additional single dose of ketorolac (0.5 mg/kg) at the conclusion of PP. Main Outcome Measures: Safety of ketorolac was measured by significant bleeding complications and need for supplementary oxygen. Efficacy was assessed through bleeding, Face Legs Activity Cry Consolability (FLACC) scale, and opioid dose. Results: Length of stay was similar for both groups (control group 38.5 hours [95% CI: 3.6-43.3] versus study group 37.6 hours [95% CI: 31.3-44.0], P = .84). There were no significant differences in all postoperative FLACC scales. The mean dose of opioid rescue medication measured as morphine milligram equivalents did not differ between groups ( P = .56). Significant postoperative hemorrhage was not observed. Conclusions: This is the first prospective study to evaluate the safety and efficacy of single-dose ketorolac after PP. Although lack of standardization between study and historical control groups may have precluded observation of an analgesic benefit, analysis demonstrated a single dose of ketorolac after PP is safe. Further investigations with more patients and different postoperative regimens may clarify the role of ketorolac in improving pain after PP.

1 November 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
IMIshwarya S. Mamidi
Ishwarya S. Mamidi
SFScott Fassas
Scott Fassas
LPLuke J. Pasick
Luke J. Pasick
DBDaniel A. Benito
Daniel A. Benito
RLRyan Lee
Ryan Lee
PTPunam Thakkar
Punam Thakkar

15 February 2021 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Closed access
PDF file
IMIshwarya Shradha Mamidi
Ishwarya Shradha Mamidi
EMEsperanza Mantilla-Rivas
Esperanza Mantilla-Rivas
BIBrynne A. Ichiuji
Brynne A. Ichiuji
SRSohel Rana
Sohel Rana
KSKaren Ivette Ramirez Suarez
Karen Ivette Ramirez Suarez
AOAlbert K. Oh
Albert K. Oh
Objective: Oronasal fistula (ONF) is a known complication after primary palatoplasty (PP). Studies investigating the effect of perioperative antibiotics on fistula rates after PP are limited by inadequate sample size or reliance on self-reporting through national databases. In this study, the authors evaluated the association between single-dose perioperative antibiotics and postoperative fistula rates after PP at a single institution. Design: A retrospective study. Participants: Children younger than 2 years who underwent PP from April 2009 to September 2019 were included. Interventions: Patients were divided into 2 categories: Group 1 received a single intraoperative dose of IV antibiotic, while group 2 did not. Main Outcome Measure(s): Outcome measures included ONF formation, length of stay (LOS), and 30-day readmission rates. Multivariable firth logistic regression, quantile regression, and χ 2 tests were performed. Results: Of the 424 patients, 215 and 209 patients were in groups 1 and 2, respectively. The overall ONF rate was 1.9% among all patients. Patients in group 1 experienced an ONF rate of 3.3%, while patients in group 2 had an ONF rate of 0.5%. After correcting for confounding variables, the difference in ONF rates was not statistically different ( P = .68). Median LOS was 35.7 hours and 35.5 hours ( P = .17), while the rate of readmission within 30 days was 4.7% and 2.4% for group 1 and 2, respectively ( P = .96). Conclusions: Administration of a single-dose perioperative antibiotic did not decrease fistula formation after PP, nor did it affect the patient’s LOS or 30-day readmission rate.